These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Effect of pectins on glucose tolerance and insulinemia (IRI) in patients with diabetes mellitus type 2 associated with obesity]. Górnicka M; Leowski J; Tatoń J Pol Tyg Lek; 1984 Apr; 39(18):593-5. PubMed ID: 6399368 [No Abstract] [Full Text] [Related]
6. Obesity and diabetes. Bompiani GD; Laudicina E Isr J Med Sci; 1972 Jun; 8(6):823-6. PubMed ID: 5051806 [No Abstract] [Full Text] [Related]
7. The dietetic treatment of diabetes mellitus. Mehnert H Horm Metab Res; 1974; Suppl 4():183-6. PubMed ID: 4418893 [No Abstract] [Full Text] [Related]
8. [The hyperinsulinic syndrome with diabetes mellitus in the development of human obesity]. Eşanu C; Klepsch I; Mitrache L; Juvina E Stud Cercet Endocrinol; 1973; 24(5):373-85. PubMed ID: 4745107 [No Abstract] [Full Text] [Related]
9. [A better estimation of beta-langerhans function in diabetes mellitus. The insulin-secretion coefficient]. Duprey J; Lubetzki J; Azerad E Presse Med (1893); 1970 Nov; 78(47):2057-60. PubMed ID: 4921672 [No Abstract] [Full Text] [Related]
10. [A new beta cell efficiency test in the islands of Langerhans]. Páv J; Srámková J Vnitr Lek; 1977 Jun; 23(7):639-46. PubMed ID: 331663 [No Abstract] [Full Text] [Related]
11. Dietary fiber: diabetes and obesity. Anderson JW; Bryant CA Am J Gastroenterol; 1986 Oct; 81(10):898-906. PubMed ID: 3020968 [No Abstract] [Full Text] [Related]
13. [Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate]. Bruns W; Rjasanowski I; Wulfert P; Michael R; Knospe S; Hildmann W Endokrinologie; 1974 Nov; 64(1):2-12. PubMed ID: 4466653 [No Abstract] [Full Text] [Related]
14. [Diagnostic value of exploratory tests for diabetes mellitus]. Mincu I Med Interna (Bucur); 1969 Apr; 21(4):387-94. PubMed ID: 5803842 [No Abstract] [Full Text] [Related]
15. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment. Leckström A; Ziv E; Shafrir E; Westermark P Pancreas; 1997 Nov; 15(4):358-66. PubMed ID: 9361089 [TBL] [Abstract][Full Text] [Related]
16. Role of diet and genetics in the development of angiopathy in diabetes. Cohen AM; Teitelbaum A; Briller S; Rosenmann E; Yanko L; Shafrir E Horm Metab Res; 1974; Suppl 4():117-23. PubMed ID: 4417198 [No Abstract] [Full Text] [Related]
17. Obesity, islet function and diabetes mellitus. Pfeiffer EF Acta Endocrinol Suppl (Copenh); 1973; 173():181. PubMed ID: 4579928 [No Abstract] [Full Text] [Related]
18. Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes. Aizawa T; Taguchi N; Sato Y; Nakabayashi T; Kobuchi H; Hidaka H; Nagasawa T; Ishihara F; Itoh N; Hashizume K J Pharmacol Exp Ther; 1995 Oct; 275(1):194-9. PubMed ID: 7562549 [TBL] [Abstract][Full Text] [Related]
19. Dissociation of the obesity-hyperinsulinism relationship following dietary restriction and hyperalimentation. Drenick EJ; Brickman AS; Gold EM Am J Clin Nutr; 1972 Aug; 25(8):746-55. PubMed ID: 4558367 [No Abstract] [Full Text] [Related]
20. The clinical relevance of pancreatic B-cell hyperplasia, hyperinsulinism and insulin insensitivity in non-insulin dependent diabetes mellitus. Mahler RJ Horm Metab Res; 1987 Nov; 19(11):565-8. PubMed ID: 3323021 [No Abstract] [Full Text] [Related] [Next] [New Search]